HOME >> MEDICINE >> NEWS
COOL AID safe after stroke, may deter side effect of clot-busters

DALLAS, August 3 Cooling the brain after an ischemic stroke may limit both initial tissue damage caused by a stroke as well as subsequent damage resulting from the restoration of blood flow after using clot-busting drugs, according to a report in the August issue of Stroke: Journal of the American Heart Association.

The irony is that while restoration of blood flow is a prerequisite for recovery, sometimes this restoration, if it occurs into already damaged tissue, can paradoxically make things worse and thereby antagonize the benefit that the patient may have otherwise enjoyed, says Michael A. De Georgia, M.D., co-principal investigator and head of the Neurological Intensive Care Program at The Cleveland Clinic Foundation.

De Georgia and colleagues found that inducing moderate hypothermia after a stroke is feasible and safe. Preliminary results of this study, which researchers call COOL AID (COOLing for Acute Ischemic Brain Damage) were presented at the American Stroke Associations 26th International Stroke Conference in February.

Some individuals are severely disabled by strokes partly because they have irreversibly damaged brain tissue by the time they arrive at the hospital. Clot-busting drugs can restore blood flow and limit tissue damage if delivered within three hours of stroke symptom onset. Yet, sometimes restoring blood flow causes more tissue damage known as reperfusion injury. This injury occurs when the rush of restored blood flow causes more insult to already injured tissue. Some experiments have indicated that hypothermia (lowered body temperature) can suppress the release of oxygen free radicals and inflammatory responses known to play a role in reperfusion injury.

The goal of this pilot study was to provide brain protection to patients at high risk of developing large strokes by combining strategies to restore blood flow with hypothermia. After clot-busting drugs showed little or no improvement, researchers induced s
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
2-Aug-2001


Page: 1 2 3

Related medicine news :

1. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
2. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
3. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
4. New scale predicts recovery of consciousness from coma after brain injury
5. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
6. Marijuana use affects blood flow in brain even after abstinence
7. Bone density appears to recover after adolescents discontinue injected contraceptive
8. Rehabilitation can restore some vision after stroke
9. Reviparin effective in reducing risk of death after heart attack
10. Early seizures after epilepsy surgery predict more seizures
11. Insulin resistance intervention after stroke focus of $33 million grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: COOL AID safe after stroke may deter side effect clot busters

(Date:6/19/2013)... along with the Japanese government and the Bill ... bolster Japan,s contribution to global health through the ... a press conference held as a side event ... Development (TICAD V). , Representatives from each of ... Labour and Welfare, the Ministry of Foreign Affairs, ...
(Date:6/19/2013)... Dental professionals are increasingly monitoring end tidal carbon ... sedation, a patient’s breathing depth and rate decrease. ... to update its guidelines to require etCO2 monitoring, or ... to increase safety in procedures. This amendment to Section ... effect July 1. , The Oregon Board of ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... Brightree LLC , the leading provider of cloud-based ... care industry, has been ranked for the first time - ... (HCI 100) list. This prestigious list features the top ... revenue during the last fiscal year. Since 2005, Brightree’s revenue ... the company has built its organization to more than 500 ...
(Date:6/19/2013)... Guests at the Residence Inn Scottsdale Paradise Valley ... go to bed or rise early thanks to a new ... , Crafty travelers will have a little extra change in ... Paradise Valley hotel’s Book Early and Save Up to ... notice, guests can enjoy the year-round Scottsdale sunshine in deluxe ...
Breaking Medicine News(10 mins):Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... , June 19, 2013   Life ... announces a licensing agreement granting Suzhou Ribo Life ... manufacture siRNA therapeutics in China ... will formulate proprietary siRNA molecules in combination with ... to address human diseases with high unmet medical ...
(Date:6/19/2013)... INDIANAPOLIS , 19. Juni 2013 ... bekannt, dass mit der Entwicklung von ... bahnbrechender Schritt in der Beschichtung mit ... die Vorteile von biokompatiblem Parylene mit ... effektive Beseitigung schädlicher Mikroorganismen auf beschichteten ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Cached News: